Abstract
Saccharomyces cerevisiae Gal11, a component of the holoenzyme of RNA polymerase II, interacts through its functional domains A and B with the small (Tfa2) and large (Tfa1) subunits of the general transcription factor (TF) IIE, respectively. We have recently suggested that Gal11 functions through a common pathway with TFIIE in transcriptional regulation (Sakurai, H., and Fukasawa, T. (1997) J. Biol. Chem. 272, 32663-32669). Here, we report that the activity of the TFIIH-associated kinase, responsible for phosphorylation of the largest subunit of RNA polymerase II at the carboxyl-terminal domain (CTD), is enhanced cooperatively by Gal11 and TFIIE. The enhancement of CTD phosphorylation was observed in the holoenzyme of RNA polymerase II, but not in its core enzyme. The stimulatory effect was completely abolished in the absence of either domain B of Gal11 or the Tfa1 subunit of TFIIE, suggesting that the domain B-Tfa1 interaction is necessary, if not sufficient, for an extensive phosphorylation of the CTD by TFIIH. Stimulation of basal transcription by Gal11 was coupled with enhancement of TFIIH-catalyzed CTD phosphorylation in a cell-free transcription system, suggesting that Gal11 activates transcription by stimulating the CTD phosphorylation in the cell.
Highlights
Saccharomyces cerevisiae Gal11, a component of the holoenzyme of RNA polymerase II, interacts through its functional domains A and B with the small (Tfa2) and large (Tfa1) subunits of the general transcription factor (TF) IIE, respectively
A holoRNAPII preparation from a GAL11 wild-type yeast was incubated with TFIIH in the presence of [␥-32P]ATP, and the phosphorylated proteins were fractionated on an SDSpolyacrylamide gel and visualized by autoradiography
Using yeast RNA polymerase II (RNAPII) holoenzyme as substrate, we have demonstrated that carboxyl-terminal domain (CTD) phosphorylation catalyzed by TFIIH is significantly enhanced by a cooperative function of Gal11 and TFIIE
Summary
Plasmid pSK720 contains polyhistidine-tagged full-length GAL11 in the pQE32 vector (QIAGEN Inc.) [22]. Expression constructs of Gal11-⌬A (pSK723) or Gal11-⌬B (pSK724) were created by removal of domain A (amino acids 866 –929) or domain B (amino acids 48 –326) of Gal11 [24] from pSK720, respectively
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.